Target Name: CHP2
NCBI ID: G63928
Review Report on CHP2 Target / Biomarker Content of Review Report on CHP2 Target / Biomarker
CHP2
Other Name(s): Calcineurin B homologous protein 2 | Hepatocellular carcinoma-associated antigen 520 | HCA520 | hepatocellular carcinoma-associated antigen 520 | Calcineurin-like EF hand protein 2 | Hepatocellular carcinoma antigen gene 520 | calcineurin like EF-hand protein 2 | hepatocellular carcinoma antigen gene 520 | Calcineurin like EF-hand protein 2 | CHP2_HUMAN

CHP2: A Protein Interaction and Cell Signaling Target

CHP2, also known as Calcineurin B homologous protein 2, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the calcineurin family of proteins, which are involved in a variety of cellular processes, including cell signaling , muscle relaxation, and inflammation. One of the unique features of CHP2 is its ability to interact with the protein kinase kinase A1 (PKA1), which is a key regulator of many cellular processes.

CHP2 has been shown to play a role in a variety of physiological processes in the body, including the regulation of inflammation, cell signaling, and muscle relaxation. For example, studies have shown that CHP2 is involved in the regulation of inflammation in the brain, and that it can help to protect against neurodegenerative diseases. Additionally, CHP2 has been shown to play a role in the regulation of cell signaling, particularly in the regulation of the neurotransmitter serotonin.

In addition to its role in regulation of cellular processes, CHP2 has also been shown to be a potential drug target. Its ability to interact with PKA1, as well as its involvement in a variety of physiological processes, make it an attractive target for drug development.

One of the challenges in studying CHP2 is its relatively small size, as proteins with this size tend to be difficult to study. However, researchers have been able to use a variety of techniques to study its function, including biochemical assays, cell-based assays , and animal models.

In addition to its potential as a drug target, CHP2 is also of interest as a biomarker. Its involvement in a variety of physiological processes makes it a potential indicator of the overall health of a cell or organism. This makes it an attractive candidate for use as a diagnostic or predictive marker in a variety of diseases.

In conclusion, CHP2 is a protein that has been shown to play a role in a variety of physiological processes throughout the body. Its ability to interact with PKA1 and its involvement in the regulation of cellular processes make it an attractive target for drug development. Additionally , its potential as a biomarker for the overall health of cells and organisms makes it a valuable tool for the study of disease.

Protein Name: Calcineurin Like EF-hand Protein 2

Functions: Functions as an integral cofactor in cell pH regulation by controlling plasma membrane-type Na(+)/H(+) exchange activity. Binds to and activates SLC9A1/NHE1 in a serum-independent manner, thus increasing pH and protecting cells from serum deprivation-induced death. Also plays a role in the regulation of cell proliferation and tumor growth by increasing the phosphatase activity of PPP3CA in a calcium-dependent manner. Activator of the calcineurin/NFAT signaling pathway. Involved in the cytoplasmic translocation of the transcription factor NFATC3 to the nucleus

The "CHP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CHPF | CHPF2 | CHPT1 | CHRAC1 | CHRD | CHRDL1 | CHRDL2 | CHRFAM7A | CHRM1 | CHRM2 | CHRM3 | CHRM3-AS2 | CHRM4 | CHRM5 | CHRNA1 | CHRNA10 | CHRNA2 | CHRNA3 | CHRNA4 | CHRNA5 | CHRNA6 | CHRNA7 | CHRNA9 | CHRNB1 | CHRNB2 | CHRNB3 | CHRNB4 | CHRND | CHRNE | CHRNG | Chromobox protein homolog | Chromodomain Helicase DNA Binding Protein | Chromosome 10 open reading frame 115 | Chromosome 16 open reading frame 47 | Chromosome 17 open reading frame 47 | Chromosome 6 open reading frame 183 | CHROMR | CHST1 | CHST10 | CHST11 | CHST12 | CHST13 | CHST14 | CHST15 | CHST2 | CHST3 | CHST4 | CHST5 | CHST6 | CHST7 | CHST8 | CHST9 | CHSY1 | CHSY3 | CHTF18 | CHTF8 | CHTOP | CHUK | CHURC1 | CHURC1-FNTB | Chymotrypsin | CIAO1 | CIAO2A | CIAO2AP2 | CIAO2B | CIAO3 | CIAPIN1 | CIART | CIB1 | CIB2 | CIB3 | CIB4 | CIBAR1 | CIBAR1-DT | CIBAR1P1 | CIBAR1P2 | CIBAR2 | CIC | CICP10 | CICP11 | CICP17 | CICP25 | CICP5 | CICP7 | CIDEA | CIDEB | CIDEC | CIDECP1 | CIITA | CILK1 | CILP | CILP2 | CINP | CIP2A | CIPC | CIR1 | CIRBP | CIRBP-AS1 | CIROP | CISD1